Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Government Unveils National Framework to Strengthen ITDAs and ITDPs
8+ hour, 12+ min ago (484+ words) New Delhi: Union Minister for Tribal Affairs Shri Jual Oram and Dr. R. Balasubramaniam, Member, NITI Aayog, on Saturday jointly released the National Framework for Strengthening of ITDAs and ITDPs and the Operational Guidelines for Strengthening of ITDAs and ITDPs, marking…...
Sumitomo Chemicals India Sees Strong Profit Growth, Expands Product and Manufacturing Pipeline
7+ hour, 28+ min ago (631+ words) New Delhi: Sumitomo Chemicals India Ltd reported a resilient performance in the first quarter of FY27, with profit after tax rising around 20 per cent year-on-year to Rs 214 crore, even as revenue remained broadly flat amid challenging monsoon conditions and weaker domestic…...
CATL and Quinbrook Build on Supernode Partnership Following Stage 2 and Stage 3 Major Milestones
23+ hour, 44+ min ago (239+ words) BRISBANE, Australia, Aug. 15, 2026 /PRNewswire/ — Quinbrook’s Supernode battery energy storage project has completed Stage 2 commercial operation and reached financial close on A$469 million financing for Stage 3, marking a further milestone in the phased development of Australia’s largest operational BESS campus. With…...
VICTORINOX INDIA WELCOMES ABHAY DEOL AS A FRIEND OF THE BRAND
1+ day, 9+ hour ago (367+ words) MUMBAI, India, Aug. 15, 2026 /PRNewswire/ — Victorinox India today announced actor Abhay Deol as a Friend of the Brand for its watch portfolio for the coming 18 months. Known for his authenticity, independent spirit and thoughtful approach to life, Deol reflects values that…...
Handloom Haat Opens at Janpath, Bringing India’s Textile Heritage Under One Roof – Content Media Solution
1+ day, 6+ hour ago (227+ words) New Delhi, August 15, 2026: Union Textiles Minister Giriraj Singh inaugurated Handloom Haat – The Handloom Experience Centre at Janpath, New Delhi, creating a new platform that brings together India’s traditional weaving heritage, contemporary design, artisans, brands and retail. The Minister also unveiled…...
Handloom Haat Opens at Janpath, Bringing India???s Textile Heritage Under One Roof
1+ day, 6+ hour ago (199+ words) New Delhi, August 15, 2026: Union Textiles Minister Giriraj Singh inaugurated Handloom Haat – The Handloom Experience Centre at Janpath, New Delhi, creating a new platform that brings together India’s traditional weaving heritage, contemporary design, artisans, brands and retail. The Minister also unveiled…...
Kia India Expands Dealer Training Network with New Academy in Ahmedabad, Its Second Facility Pan-India
1+ day, 11+ hour ago (18+ words) Content Media Solution...
Juniper Hotels to Invest Rs 850 Crore to Develop Landmark Luxury Hotel in New Delhi
2+ day, 3+ hour ago (281+ words) August 14: Juniper Hotels Limited (“Juniper/”Company”), will develop a luxury 5-star hotel in Sector 23, Dwarka, Delhi, adding approximately 550 keys, involving a capital expenditure of around INR 850 crore. Upon completion, Juniper’s presence in New Delhi is expected to expand to approximately…...
RIMAN Highlights Product and Ingredient Innovation at RIMAN North America Convention 2026
2+ day, 4+ hour ago (318+ words) Content Media Solution SEOUL, South Korea, Aug. 14, 2026 /PRNewswire/ — RIMAN, a direct selling company specializing in K-beauty skincare and wellness, successfully concluded its North America Convention 2026 in Las Vegas, Nevada, from August 7–9, 2026. The three-day event brought together thousands of distributors and…...
ArkBio???s RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial
2+ day, 2+ hour ago (116+ words) SHANGHAI, Aug. 14, 2026 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that the U.S. Food and Drug Administration (FDA) has approved ziresovir (AK0529) for a phase II clinical trial in the severely ill RSV infected infant patients, including the ones…...